---
title: "Dexlansoprazole - Gastroesophageal reflux disease"
sidebar: mydoc_sidebar
permalink: db05351-mesh-d005764-1.html
toc: false 
---


Path ID: `DB05351_MESH_D005764_1`
{% include image.html url="images/db05351-mesh-d005764-1.png" file="db05351-mesh-d005764-1.png" alt="db05351-mesh-d005764-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D064748 | Dexlansoprazole | Drug |
| UniProt:P20648 | Potassium-transporting ATPase alpha chain 1 | Protein |
| UniProt:P51164 | Potassium-transporting ATPase subunit beta | Protein |
| GO:0001696 | Gastric acid secretion | BiologicalProcess |
| MESH:D005744 | Gastric Acid | ChemicalSubstance |
| MESH:D005764 | Gastroesophageal reflux disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Dexlansoprazole | DECREASES ACTIVITY OF | Potassium-Transporting Atpase Alpha Chain 1 |
| Dexlansoprazole | DECREASES ACTIVITY OF | Potassium-Transporting Atpase Subunit Beta |
| Potassium-Transporting Atpase Alpha Chain 1 | POSITIVELY REGULATES | Gastric Acid Secretion |
| Potassium-Transporting Atpase Subunit Beta | POSITIVELY REGULATES | Gastric Acid Secretion |
| Gastric Acid Secretion | INCREASES ABUNDANCE OF | Gastric Acid |
| Gastric Acid | POSITIVELY CORRELATED WITH | Gastroesophageal Reflux Disease |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB05351#mechanism-of-action](https://go.drugbank.com/drugs/DB05351#mechanism-of-action){:target="_blank"}